- A Novel Angiotensin Type I Receptor Antagonist, Fimasartan, Prevents Doxorubicin-induced Cardiotoxicity in Rats
-
Chang SA, Lim BK, Lee YJ, Hong MK, Choi JO, Jeon ES
- KMID: 2155468
- J Korean Med Sci.
- 2015 May;30(5):559-568.
- doi: 10.3346/jkms.2015.30.5.559
Angiotensin receptor blockers (ARBs) have organ-protective effects in heart failure and may be also effective in doxorubicin-induced cardiomyopathy (DOX-CMP); however, the efficacy of ARBs on the prevention of DOX-CMP have... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension
-
Kim JH, Kim JM, Cho YZ, Na JH, Kim HS, Kim HA, Kang HW, Baik SK, Kwon SO, Cha SH, Kim YJ, Kim MY
- KMID: 2070256
- Clin Mol Hepatol.
- 2014 Dec;20(4):376-383.
- doi: 10.3350/cmh.2014.20.4.376
BACKGROUND/AIMS: Angiotensin receptor blockers (ARBs) inhibit activated hepatic stellate cell contraction and are thought to reduce the dynamic portion of intrahepatic resistance. This study compared the effects of combined treatment... -
- CITED
-
- Close
- SHARE
-
- Close
- Cardioprotective Effect of Fimasartan, a New Angiotensin Receptor Blocker, in a Porcine Model of Acute Myocardial Infarction
-
Sim DS, Jeong MH, Song HC, Kim J, Chong A, Bom HS, Jeong IS, Oh SG, Kim JM, Park DS, Kim JH, Lim KS, Kim MS, Ryu SH, Kim HK, Kim SS, Jang SY, Cho JY, Jeong HC, Lee KH, Park KH, Yoon NS, Yoon HJ, Kim KH, Hong YJ, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC
- KMID: 2155445
- J Korean Med Sci.
- 2015 Jan;30(1):34-43.
- doi: 10.3346/jkms.2015.30.1.34
Cardioprotective effect of fimasartan, a new angiotensin receptor blocker (ARB), was evaluated in a porcine model of acute myocardial infarction (MI). Fifty swine were randomized to group 1 (sham, n=10),... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Cilostazol on Platelet Activation in Coronary Stenting Patients Who Already Treated with Aspirin and Clopidogrel
-
Ahn JC, Song WH, Kwon JA, Park CG, Seo HS, Oh DJ, Rho YM
- KMID: 1109521
- Korean J Intern Med.
- 2004 Dec;19(4):230-236.
BACKGROUND: A recent study has shown that triple anti-platelet therapy (cilostazol+clopidogrel+aspirin) resulted in a significantly lower restenosis rate after coronary stenting than did conventional therapy (clopidogrel+aspirin). However, the anti-platelet effects... -
- CITED
-
- Close
- SHARE
-
- Close
- Myocardial Protective Effect of Tezosentan, an Endothelin Receptor Antagonist, for Ischemia-Reperfusion Injury in Experimental Heart Failure Models
-
Ryu SM, Kim HJ, Cho KR, Jo WM
- KMID: 1781994
- J Korean Med Sci.
- 2009 Oct;24(5):782-788.
- doi: 10.3346/jkms.2009.24.5.782
The myocardial protective effects of endothelin antagonist in ischemic cardiomyopathy (ICMP), doxorubicin-induced cardiomyopathy (DOX) and pressure-overload hypertrophy by transverse aortic constriction (TAC) models have been predicted to be different. The... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Irbesartan on Left Ventricular Mass and Arterial Stiffness in Hypertensive Patients
-
Park CG, Ahn JC, Hong SJ, Kim EJ, Lee SJ, Park SM, Seo HS, Oh DJ
- KMID: 1785606
- Korean J Intern Med.
- 2006 Jun;21(2):103-108.
- doi: 10.3904/kjim.2006.21.2.103
BACKGROUND: Increased aortic stiffness measured by pulse wave velocity (PWV) and left ventricular hypertrophy (LVH) are independent risk factors of cardiovascular events in hypertensive patients. We have conducted a... -
- CITED
-
- Close
- SHARE
-
- Close
